Regeneron Pharmaceuticals, Inc
1 products tracked · names used in filings: Regeneron Pharmaceuticals, Inc
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Wed 19 Aug 2026🇺🇸 FDA approval
FDA approves Pasatru (garetosmab-grts), a new medicine
Regeneron Pharmaceuticals, Inc; BLA761508; New biologic, Priority review; injectable · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Pasatru garetosmab-grts | Approved | 2026-08-19 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.